 ACADIA Pharmaceuticals, Inc. NASDAQ:ACAD Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Kathie Bishop - SVP and Head, Rare Disease External Innovation Srdjan Stankovic - President Stephen Davis - CEO Director Mark Johnson - VP, IR Brendan Teehan - EVP, COO Head of Commercial Mark Schneyer - EVP CFO Conference Call Participants Jay Olson - Oppenheimer Marc Goodman - SVB Securities Tazeen Ahmad - Bank of America Merrill Lynch Ritu Baral - Cowen and Company Neena Garg - Citigroup Gregory Renza - RBC Capital Markets Sumant Kulkarni - Canaccord Genuity Charles Duncan - Cantor Fitzgerald Co. Eddie Hickman - Guggenheim Securities Operator Good day, ladies and gentlemen, and welcome to the ACADIA Pharmaceuticals Second Quarter 2022 Financial Results Conference Call. Operator Instructions. 